Disease Markers / 2019 / Article / Tab 7

Research Article

Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals

Table 7

The clinical characteristics of the samples using by 5,000 randomly sampled data sets.

ADRB3 rs4994 genotype
T/T ()T/C ()C/C () value

Age (years)66 (17–97)65 (20–93)66 (34–91)0.41
BMI (kg/m2)22.8 (14.1–35.2)22.8 (14.5–33.7)22.9 (14.6–32.9)0.96
Diabetes (%)13.413.410.50.49
Dyslipidemia (%)55.860.148.1< 0.01
NAFLD (%)18.122.528.6< 0.01

Data are the median (range) or proportion for categorical variables. ADRB3: beta-3-adrenergic receptor; BMI: body mass index; NAFLD: nonalcoholic fatty liver disease. Analyzed by Fisher’s exact test, otherwise Kruskal Wallis test.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.